Circulating RNA as a novel tumor marker: An in vitro study of the origins and characteristics of extracellular RNA

Cancer Letters

Volumn 259, Issue 1, 2008, Pages 50-60

  Zhou, Hongxing ^a   Xu, Wenrong ^a   Qian, Hui ^a   Yin, Qin ^b   Zhu, Wei ^a   Yan, Yongmin ^a  

^a School of Medical Technology   (China)

^b JIANGSU UNIVERSITY   (China)

Author keywords

Circulating RNA; Extracellular RNA; Filtration; Hypoxia; Real time PCR

Indexed keywords

CISPLATIN; FLUOROURACIL; RIBONUCLEASE; RNA; TUMOR MARKER;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA DEGRADATION; TUMOR CELL;

ANTINEOPLASTIC AGENTS; CELL HYPOXIA; CELL PROLIFERATION; CISPLATIN; COLD; CULTURE MEDIA, CONDITIONED; FLUOROURACIL; GENE EXPRESSION; HELA CELLS; HUMANS; RIBONUCLEASES; RNA; RNA STABILITY; STOMACH NEOPLASMS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 36848998827     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.09.016     Document Type: Article

References (26)

1. Stroun M., Anker P., Beljanski M., Henri J., Lederrey C., Ojha M., et al. Presence of RNA in the nucleoprotein complex spontaneously released by human lymphocytes and frog auricles in culture. Cancer Res. 38 (1978) 3546-3554
2. Andreas J.W., Caspar R., and Lutz H. Isolation and characterization of an RNA-proteolipid complex associated with the malignant state in humans. Proc. Natl. Acad. Sci. 82 (1985) 3455-3459
3. Biggiogera M., Bottone M.G., and Pellicciari C. Nuclear RNA is extruded from apoptotic cells. J. Histochem. Cytochem. 46 (1998) 999-1005
4. Halicka H.D., Bedner E., and Darzynkiewicz Z. Segregation of RNA and separate packaging of DNA and RNA in apoptotic bodies during apoptosis. Exp. Cell Res. 260 (2000) 248-256
5. Ng E.K., Tsui N.B., Lam N.Y., Chiu R.W., Yu S.C., Lo E.S., et al. Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clin. Chem. 48 (2002) 1212-1217
6. Tsui N.B., Ng E.K., and Lo Y.M. Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin. Chem. 48 (2002) 1647-1653
7. Hasselmann D.O., Rappl G., Tilgen W., and Reinhold U. Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum. Clin. Chem. 47 (2001) 1488-1489
8. Kopreski M.S., Benko F.A., Kwak L.W., and Gocke C.D. Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin. Cancer Res. 5 (1999) 1961-1965
9. Silva J.M., Dominguez G., Silva J., Garcia J.M., Sanchez A., Rodriguez O., et al. Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics. Clin. Cancer Res. 7 (2001) 2821-2825
10. Lledo S.M., Garcia-Granero E., Dasi F., Ripoli R., Garcia S.A., Cervantes A., et al. Real time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA in patients with colorectal cancer. Colorectal Dis. 6 (2004) 236-242
11. Miura N., Maeda Y., Kanbe T., Yazama H., Takeda Y., Sato R., et al. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma. Clin. Cancer Res. 11 (2005) 3205-3209
12. Sueoka E., Sueoka N., Iwanaga K., Sato A., Suga K., Hayashi S., et al. Detection of plasma hnRNP B1 mRNA, a new cancer biomarker, in lung cancer patients by quantitative real-time polymerase chain reaction. Lung Cancer 48 (2005) 77-83
13. Schmidt B., Engel E., Carstensen T., Weickmann S., John M., Witt C., et al. Quantification of free RNA in serum and bronchial lavage: a new diagnostic tool in lung cancer detection?. Lung Cancer 48 (2005) 145-147
14. Dasi F., Martinez-Rodes P., March J.A., Santamaria J., Martinez-Javaloyas J.M., Gil M., et al. Real-time quantification of human telomerase reverse transcriptase mRNA in the plasma of patients with prostate cancer. Ann. NY Acad. Sci. 1075 (2006) 204-210
15. Li Y., Elashoff D., Oh M., Sinha U., St John M.A., Zhou X., et al. Serum circulating human mRNA profiling and its utility for oral cancer detection. J. Clin. Oncol. 24 (2006) 1754-1760
16. Wong B.C., Chan K.C., Chan A.T., Leung S.F., Chan L.Y., Chow K.C., et al. Reduced plasma RNA integrity in nasopharyngeal carcinoma patients. Clin. Cancer Res. 12 (2006) 2512-2516
17. Fleischhacker M. Biology of circulating mRNA still more questions than answers?. Ann. NY Acad. Sci. 1075 (2006) 40-49
18. Shaw R.J. Glucose metabolism and cancer. Curr. Opin. Cell Biol. 18 (2006) 598-608
19. Lal A., Peters H., St. Croix B., Haroon Z.A., Dewhirst M.W., Strausberg R.L., et al. Transcriptional response to hypoxia in human tumors. J. Natl. Cancer Inst. 93 (2001) 1337-1343
20. Chaudary N., and Hill R.P. Hypoxia and metastasis in breast cancer. Breast Dis. 26 (2006-2007) 55-64
21. Swarup V., and Rajeswari M.R. Circulating (cell-free) nucleic acids-A promising, non-invasive tool for early detection of several human diseases. FEBS Lett. 581 (2007) 795-799
22. Levine B., and Klionsky D.J. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev. Cell 6 (2004) 463-477
23. Hoffman N.E., Bent A.F., and Hanson A.D. Induction of lactate dehydrogenase isozymes by oxygen deficit in barley root tissue. Plant Physiol. 82 (1986) 658-663
24. Bottcher K., Wenzel A., and Warnecke J.M. Investigation of the origin of extracellular RNA in human cell culture. Ann. NY Acad. Sci. 1075 (2006) 50-56
25. Wong B.C., and Dennis Lo Y.M. Plasma RNA integrity analysis: methodology and validation. Ann. NY Acad. Sci. 1075 (2006) 174-178
26. Talal E.H., Raja S., Kelly L., Bigbee W.L., Kirkwood J.M., Luketich J.D., et al. Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin. Chem. 50 (2004) 564-573